Missed Rx Price Hikes Will Be Skipped By Manufacturers, McKesson Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Manufacturer price increases that were anticipated for the July quarter likely will be skipped altogether, McKesson CEO John Hammergren said
You may also be interested in...
AmerisourceBergen Opens Its Books To Manufacturers In Contract Talks
"Manufacturers have lost track of the real value" wholesalers add to the channel, CEO Yost says. McKesson and Cardinal may also offer transparency in fee-for-service negotiations, Yost speculates.
McKesson To Pay $960 Mil. To Settle Most Of HBOC Litigation
McKesson also reserves $240 mil. for additional settlements, for a total negative impact of $1.2 bil. The company will take the charge in the third quarter (ended Dec. 31), which already was going to be worse than originally expected.
McKesson To Pay $960 Mil. To Settle Most Of HBOC Litigation
McKesson also reserves $240 mil. for additional settlements, for a total negative impact of $1.2 bil. The company will take the charge in the third quarter (ended Dec. 31), which already was going to be worse than originally expected.